Table of Content

1 INTRODUCTION (Page No. - 26)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 SEGMENTS CONSIDERED
           1.3.2 INCLUSIONS AND EXCLUSIONS
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key secondary sources
                    2.1.1.2 Key data from secondary sources
                    2.1.1.3 Objectives of secondary research
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Key industry insights
                    2.1.2.4 Breakdown of primaries
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Company revenue estimation approach
                    2.2.1.2 Company presentations and primary interviews
                    2.2.1.3 Growth forecast
                    2.2.1.4 CAGR projections
           2.2.2 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION 
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 GROWTH RATE ASSUMPTIONS 
    2.7 RESEARCH LIMITATIONS 
    2.8 RISK ASSESSMENT 
3 EXECUTIVE SUMMARY (Page No. - 43)
4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 BREATHING CIRCUITS MARKET OVERVIEW 
    4.2 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029 
    4.3 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029 
    4.4 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029 
    4.5 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029 
    4.6 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029 
    4.7 BREATHING CIRCUITS MARKET: REGIONAL GROWTH OPPORTUNITIES 
5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Growing prevalence of respiratory diseases
                    5.2.1.2 Rising number of emergency cases globally
                    5.2.1.3 Increasing number of surgical procedures
                    5.2.1.4 Technological advancements
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable reimbursement scenario
                    5.2.2.2 High risk of infection associated with reusable breathing circuits
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Environmental concerns related to single-use and non-biodegradable breathing circuits
    5.3 PRICING ANALYSIS 
    5.4 PATENT ANALYSIS 
           5.4.1 LIST OF MAJOR PATENTS
    5.5 VALUE CHAIN ANALYSIS 
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 TRADE ANALYSIS 
           5.7.1 IMPORT DATA (HS CODE 901920)
           5.7.2 EXPORT DATA (HS CODE 901920)
    5.8 ECOSYSTEM ANALYSIS 
           5.8.1 ROLE IN ECOSYSTEM
    5.9 PORTER’S FIVE FORCES ANALYSIS 
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF BUYERS
           5.9.4 BARGAINING POWER OF SUPPLIERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.10.2 KEY BUYING CRITERIA
    5.11 REGULATORY ANALYSIS 
           5.11.1 REGULATORY LANDSCAPE
                    5.11.1.1 North America
                               5.11.1.1.1 US
                               5.11.1.1.2 Canada
                    5.11.1.2 Europe
                    5.11.1.3 Asia Pacific
                               5.11.1.3.1 China
                               5.11.1.3.2 Japan
                               5.11.1.3.3 India
                    5.11.1.4 Latin America
                               5.11.1.4.1 Brazil
                               5.11.1.4.2 Mexico
                    5.11.1.5 Middle East
                    5.11.1.6 Africa
           5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.12 TECHNOLOGY ANALYSIS 
           5.12.1 KEY TECHNOLOGIES
                    5.12.1.1 Single-limb breathing circuits
           5.12.2 COMPLEMENTARY TECHNOLOGIES
                    5.12.2.1 Dual-limb breathing circuits
           5.12.3 ADJACENT TECHNOLOGIES
                    5.12.3.1 Low dead space circuits
    5.13 KEY CONFERENCES AND EVENTS IN 2024–2025 
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
    5.15 INVESTMENT AND FUNDING SCENARIO 
    5.16 IMPACT OF AI/GEN AI ON BREATHING CIRCUITS MARKET 
           5.16.1 KEY USE CASES
6 BREATHING CIRCUITS MARKET, BY USAGE (Page No. - 86)
    6.1 INTRODUCTION 
    6.2 DISPOSABLE BREATHING CIRCUITS 
           6.2.1 GROWING EMPHASIS ON INFECTION CONTROL AND PATIENT SAFETY TO DRIVE MARKET
    6.3 REUSABLE BREATHING CIRCUITS 
           6.3.1 COST-EFFECTIVENESS AND REDUCED ENVIRONMENTAL FOOTPRINT TO PROPEL MARKET GROWTH
7 BREATHING CIRCUITS MARKET, BY PATIENT TYPE (Page No. - 95)
    7.1 INTRODUCTION 
    7.2 ADULT PATIENTS 
           7.2.1 INCREASING SURGICAL PROCEDURES AND GROWING PREVALENCE OF LIFESTYLE-RELATED DISEASES TO BOOST MARKET GROWTH
    7.3 PEDIATRIC AND NEONATAL PATIENTS 
           7.3.1 INCREASING TIMELY INTERVENTION AND TREATMENT IN PEDIATRIC CARE TO FUEL MARKET GROWTH
8 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE (Page No. - 105)
    8.1 INTRODUCTION 
    8.2 SINGLE-LIMB BREATHING CIRCUITS 
           8.2.1 SIMPLE DESIGN AND EASE OF USE TO AID MARKET GROWTH
    8.3 DUAL-LIMB BREATHING CIRCUITS 
           8.3.1 HIGH DEMAND FOR ADVANCED VENTILATION SOLUTIONS AND INCREASED PATIENT COMFORT TO SPUR MARKET GROWTH
9 BREATHING CIRCUITS MARKET, BY APPLICATION (Page No. - 114)
    9.1 INTRODUCTION 
    9.2 ANESTHESIA 
           9.2.1 INCREASING NUMBER OF SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET GROWTH
    9.3 RESPIRATORY DYSFUNCTION 
           9.3.1 RISING PREVALENCE OF CHRONIC PULMONARY DISEASES AND SLEEP APNEA TO FUEL MARKET GROWTH
    9.4 OTHER APPLICATIONS 
10 BREATHING CIRCUITS MARKET, BY END USER (Page No. - 128)
     10.1 INTRODUCTION 
     10.2 HOSPITALS 
             10.2.1 INCREASING NUMBER OF HOSPITALS AND RISING GOVERNMENT HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
     10.3 AMBULATORY SURGERY CENTERS 
             10.3.1 FOCUS ON COST-EFFECTIVE AND IMPROVED PATIENT EXPERIENCE TO DRIVE MARKET
     10.4 CLINICS 
             10.4.1 RISING PREVALENCE OF TARGET DISEASES TO SUPPORT MARKET GROWTH
     10.5 OTHER END USERS 
11 BREATHING CIRCUITS MARKET, BY REGION (Page No. - 143)
     11.1 INTRODUCTION 
     11.2 NORTH AMERICA 
             11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
             11.2.2 US
                        11.2.2.1 US to dominate North American breathing circuits market during study period
             11.2.3 CANADA
                        11.2.3.1 High geriatric population and improved healthcare infrastructure to propel market growth
     11.3 EUROPE 
             11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
             11.3.2 GERMANY
                        11.3.2.1 High healthcare spending and favorable government policies to favor market growth
             11.3.3 FRANCE
                        11.3.3.1 Advanced healthcare system and increased number of surgeries to augment market growth
             11.3.4 UK
                        11.3.4.1 Rising geriatric population and increasing initiatives by public and private organizations to aid market growth
             11.3.5 ITALY
                        11.3.5.1 Improved quality of medical care and high geriatric population to spur market growth
             11.3.6 SPAIN
                        11.3.6.1 Increased incidence of chronic diseases and improved healthcare infrastructure to drive demand
             11.3.7 REST OF EUROPE
     11.4 ASIA PACIFIC 
             11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
             11.4.2 JAPAN
                        11.4.2.1 Presence of universal healthcare reimbursement policy and high geriatric population to drive market
             11.4.3 CHINA
                        11.4.3.1 Increasing number of hospitals and growing public access to modern healthcare to fuel market growth
             11.4.4 INDIA
                        11.4.4.1 Large patient population and developed healthcare sector to boost market growth
             11.4.5 AUSTRALIA
                        11.4.5.1 Increasing prevalence of chronic respiratory diseases to fuel market
             11.4.6 SOUTH KOREA
                        11.4.6.1 Increasing private hospitals and growing medical tourism to support market growth
             11.4.7 REST OF ASIA PACIFIC
     11.5 LATIN AMERICA 
             11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
             11.5.2 BRAZIL
                        11.5.2.1 Developed public health systems and improved healthcare infrastructure to favor market growth
             11.5.3 MEXICO
                        11.5.3.1 Modern healthcare infrastructure and availability of advanced surgical techniques to augment market growth
             11.5.4 REST OF LATIN AMERICA
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 DEVELOPED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT HEALTH POLICIES TO PROPEL MARKET
             11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
     11.7 GCC COUNTRIES 
             11.7.1 INCREASING GOVERNMENT HEALTHCARE SPENDING AND GROWING MEDICAL TOURISM TO AID MARKET GROWTH
             11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
12 COMPETITIVE LANDSCAPE (Page No. - 209)
     12.1 INTRODUCTION 
     12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BREATHING CIRCUITS MARKET
     12.3 REVENUE ANALYSIS, 2021–2023 
     12.4 MARKET SHARE ANALYSIS, 2023 
     12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
             12.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2023
                        12.5.5.1 Company footprint
                        12.5.5.2 Usage footprint
                        12.5.5.3 Application footprint
                        12.5.5.4 Region footprint
     12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
             12.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023
     12.7 COMPANY VALUATION AND FINANCIAL METRICS 
     12.8 BRAND/PRODUCT COMPARISON 
     12.9 COMPETITIVE SCENARIO 
             12.9.1 PRODUCT LAUNCHES
             12.9.2 DEALS
13 COMPANY PROFILES (Page No. - 225)
     13.1 KEY PLAYERS 
             13.1.1 DRÄGERWERK AG & CO. KGAA
                        13.1.1.1 Business overview
                        13.1.1.2 Products offered
                        13.1.1.3 Recent developments
                                     13.1.1.3.1 Product launches
                                     13.1.1.3.2 Deals
                        13.1.1.4 MnM view
                                     13.1.1.4.1 Key strengths
                                     13.1.1.4.2 Strategic choices
                                     13.1.1.4.3 Weaknesses and competitive threats
             13.1.2 MEDTRONIC
                        13.1.2.1 Business overview
                        13.1.2.2 Products offered
                        13.1.2.3 Recent developments
                                     13.1.2.3.1 Deals
                        13.1.2.4 MnM view
                                     13.1.2.4.1 Key strengths
                                     13.1.2.4.2 Strategic choices
                                     13.1.2.4.3 Weaknesses and competitive threats
             13.1.3 CARDINAL HEALTH
                        13.1.3.1 Business overview
                        13.1.3.2 Products offered
                        13.1.3.3 Recent developments
                                     13.1.3.3.1 Expansions
                        13.1.3.4 MnM view
                                     13.1.3.4.1 Key strengths
                                     13.1.3.4.2 Strategic choices
                                     13.1.3.4.3 Weaknesses and competitive threats
             13.1.4 FISHER & PAYKEL HEALTHCARE LIMITED
                        13.1.4.1 Business overview
                        13.1.4.2 Products offered
                        13.1.4.3 Recent developments
                                     13.1.4.3.1 Expansions
                        13.1.4.4 MnM view
                                     13.1.4.4.1 Key strengths
                                     13.1.4.4.2 Strategic choices
                                     13.1.4.4.3 Weaknesses and competitive threats
             13.1.5 RESMED
                        13.1.5.1 Business overview
                        13.1.5.2 Products offered
                        13.1.5.3 Recent developments
                                     13.1.5.3.1 Expansions
                        13.1.5.4 MnM view
                                     13.1.5.4.1 Key strengths
                                     13.1.5.4.2 Strategic choices
                                     13.1.5.4.3 Weaknesses and competitive threats
             13.1.6 AMBU A/S
                        13.1.6.1 Business overview
                        13.1.6.2 Products offered
                        13.1.6.3 Recent developments
                                     13.1.6.3.1 Expansions
             13.1.7 GE HEALTHCARE
                        13.1.7.1 Business overview
                        13.1.7.2 Products offered
                        13.1.7.3 Recent developments
                                     13.1.7.3.1 Deals
                                     13.1.7.3.2 Expansions
             13.1.8 KONINKLIJKE PHILIPS N.V.
                        13.1.8.1 Business overview
                        13.1.8.2 Products offered
                        13.1.8.3 Recent developments
                                     13.1.8.3.1 Deals
             13.1.9 ICU MEDICAL, INC.
                        13.1.9.1 Business overview
                        13.1.9.2 Products offered
                        13.1.9.3 Recent developments
                                     13.1.9.3.1 Deals
             13.1.10 HAMILTON MEDICAL
                        13.1.10.1 Business overview
                        13.1.10.2 Products offered
             13.1.11 MEDLINE INDUSTRIES, LP
                        13.1.11.1 Business overview
                        13.1.11.2 Products offered
                        13.1.11.3 Recent developments
                                     13.1.11.3.1 Deals
                                     13.1.11.3.2 Expansions
     13.2 OTHER PLAYERS 
             13.2.1 FORCA HEALTHCARE
             13.2.2 BRAUN & CO. LIMITED
             13.2.3 INSPIRATION HEALTHCARE GROUP PLC
             13.2.4 BESMED HEALTH BUSINESS CORP.
             13.2.5 EAKIN HEALTHCARE
             13.2.6 BOMIMED
             13.2.7 FLEXICARE (GROUP) LIMITED
             13.2.8 BIO-MED DEVICES
             13.2.9 AIRLIFE
             13.2.10 MERCURY MEDICAL
             13.2.11 INTERSURGICAL LTD.
             13.2.12 FAIRMONT MEDICAL PRODUCTS PTY LTD.
             13.2.13 BREAS MEDICAL AB
             13.2.14 GPC MEDICAL LTD.
14 APPENDIX (Page No. - 274)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS

List of Figures

FIGURE 1 BREATHING CIRCUITS MARKET: SEGMENTS CONSIDERED 27
FIGURE 2 BREATHING CIRCUITS MARKET: YEARS CONSIDERED 28
FIGURE 3 BREATHING CIRCUITS MARKET: RESEARCH DESIGN 30
FIGURE 4 BREATHING CIRCUITS MARKET: KEY DATA FROM SECONDARY SOURCES 32
FIGURE 5 BREATHING CIRCUITS MARKET: KEY PRIMARY SOURCES 33
FIGURE 6 BREATHING CIRCUITS MARKET: KEY INDUSTRY INSIGHTS 35
FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 9 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 37
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 11 BREATHING CIRCUITS MARKET: TOP-DOWN APPROACH 39
FIGURE 12 DATA TRIANGULATION METHODOLOGY 40
FIGURE 13 BREATHING CIRCUITS MARKET: STUDY ASSUMPTIONS 41
FIGURE 14 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029 (USD MILLION) 43
FIGURE 15 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION) 44
FIGURE 16 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029 (USD MILLION) 44
FIGURE 17 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 45
FIGURE 18 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46
FIGURE 19 BREATHING CIRCUITS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 46
FIGURE 20 INCREASING NUMBER OF SURGERIES AND GROWING PREVALENCE OF
CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET 48
FIGURE 21 DISPOSABLE BREATHING CIRCUITS TO DOMINATE BREATHING CIRCUITS USAGE MARKET IN 2029 48
FIGURE 22 ADULT PATIENTS SEGMENT TO COMMAND LARGER MARKET SHARE DURING FORECAST PERIOD 49
FIGURE 23 SINGLE-LIMB BREATHING CIRCUITS TO ACCOUNT FOR LARGER MARKET SHARE BETWEEN 2024 AND 2029 49
FIGURE 24 ANESTHESIA TO COMMAND LARGEST SHARE IN BREATHING CIRCUITS APPLICATION MARKET DURING STUDY PERIOD 50
FIGURE 25 HOSPITALS TO DOMINATE END USER MARKET DURING FORECAST PERIOD 50
FIGURE 26 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
FIGURE 27 BREATHING CIRCUITS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 28 US: NUMBER OF HOSPITAL EMERGENCY ROOM VISITS 2012–2022 (PER 1,000 POPULATION) 54
FIGURE 29 AVERAGE SELLING PRICE OF SINGLE-LIMB BREATHING CIRCUITS (2024) 61
FIGURE 30 PATENT ANALYSIS FOR BREATHING CIRCUITS (JANUARY 2014– DECEMBER 2023) 62
FIGURE 31 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 64
FIGURE 32 BREATHING CIRCUITS MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 33 BREATHING CIRCUITS MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 34 BREATHING CIRCUITS MARKET: PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BREATHING CIRCUITS 71
FIGURE 36 KEY BUYING CRITERIA FOR BREATHING CIRCUITS 72
FIGURE 37 BREATHING CIRCUITS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
FIGURE 38 NUMBER OF DEALS AND FUNDING IN BREATHING CIRCUITS MARKET 83
FIGURE 39 MARKET POTENTIAL OF AI TO ENHANCE USE OF BREATHING CIRCUITS ACROSS CLINICAL SETTINGS 84
FIGURE 40 US: AGE-ADJUSTED PREVALENCE OF COPD AMONG ADULTS AGED ?18 YEARS (2011 VS. 2021) 98
FIGURE 41 NORTH AMERICA: BREATHING CIRCUITS MARKET SNAPSHOT 145
FIGURE 42 ASIA PACIFIC: BREATHING CIRCUITS MARKET SNAPSHOT 174
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN BREATHING CIRCUITS MARKET
(2021–2023) 211
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BREATHING CIRCUITS MARKET (2023) 212
FIGURE 45 BREATHING CIRCUITS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 215
FIGURE 46 BREATHING CIRCUITS MARKET: COMPANY FOOTPRINT 216
FIGURE 47 BREATHING CIRCUITS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 219
FIGURE 48 EV/EBITDA OF KEY VENDORS 221
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 221
FIGURE 50 BREATHING CIRCUITS MARKET: PRODUCT ANALYSIS FOR DUAL-LIMB BREATHING CIRCUITS 222
FIGURE 51 DR?GERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 226
FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT (2023) 231
FIGURE 53 CARDINAL HEALTH: COMPANY SNAPSHOT (2023) 235
FIGURE 54 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2023) 239
FIGURE 55 RESMED: COMPANY SNAPSHOT (2023) 242
FIGURE 56 AMBU A/S: COMPANY SNAPSHOT (2023) 245
FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 248
FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 251
FIGURE 59 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023) 254

List of Tables

TABLE 1 BREATHING CIRCUITS MARKET: INCLUSIONS AND EXCLUSIONS 28
TABLE 2 BREATHING CIRCUITS MARKET: KEY DATA FROM PRIMARY SOURCES 34
TABLE 3 BREATHING CIRCUITS MARKET: RISK ASSESSMENT 42
TABLE 4 NUMBER OF SURGERIES PERFORMED GLOBALLY, BY COUNTRY, 2022 56
TABLE 5 INDICATIVE SELLING PRICING OF BREATHING CIRCUITS, BY PRODUCT, 2022–2024 59
TABLE 6 INDICATIVE SELLING PRICE OF BREATHING CIRCUITS, BY REGION, 2022–2024 60
TABLE 7 BREATHING CIRCUITS MARKET: LIST OF MAJOR PATENTS, 2022–2023 63
TABLE 8 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION) 66
TABLE 9 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION) 67
TABLE 10 BREATHING CIRCUITS MARKET: ROLE IN ECOSYSTEM 68
TABLE 11 BREATHING CIRCUITS MARKET: IMPACT OF PORTER’S FIVE FORCES 70
TABLE 12 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BREATHING CIRCUITS (%) 72
TABLE 13 KEY BUYING CRITERIA FOR BREATHING CIRCUITS, BY CIRCUIT TYPE 72
TABLE 14 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 74
TABLE 15 CHINA: MEDICAL DEVICES CLASSIFICATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) 75
TABLE 16 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 75
TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 22 BREATHING CIRCUITS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025 81
TABLE 23 BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 87
TABLE 24 KEY PRODUCTS IN DISPOSABLE BREATHING CIRCUITS MARKET 88
TABLE 25 DISPOSABLE BREATHING CIRCUITS MARKET, BY REGION 2022–2029 (USD MILLION) 89
TABLE 26 NORTH AMERICA: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 89
TABLE 27 EUROPE: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 90
TABLE 28 ASIA PACIFIC: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 90
TABLE 29 LATIN AMERICA: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 91
TABLE 30 KEY PRODUCTS IN REUSABLE BREATHING CIRCUITS MARKET 92
TABLE 31 REUSABLE BREATHING CIRCUITS MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 32 NORTH AMERICA: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY
2022–2029 (USD MILLION) 93
TABLE 33 EUROPE: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 93
TABLE 34 ASIA PACIFIC: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 94
TABLE 35 LATIN AMERICA: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 94
TABLE 36 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 96
TABLE 37 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR ADULT PATIENTS 98
TABLE 38 BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY REGION 2022–2029 (USD MILLION) 99
TABLE 39 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS BY COUNTRY 2022–2029 (USD MILLION) 99
TABLE 40 EUROPE: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 41 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 42 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 43 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS 102
TABLE 44 BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS BY REGION, 2022–2029 (USD MILLION) 102
TABLE 45 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY 2022–2029 (USD MILLION) 103
TABLE 46 EUROPE: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 47 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 48 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 49 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 106
TABLE 50 KEY PRODUCTS IN SINGLE-LIMB BREATHING CIRCUITS MARKET 107
TABLE 51 SINGLE-LIMB BREATHING CIRCUITS MARKET, BY REGION 2022–2029 (USD MILLION) 108
TABLE 52 NORTH AMERICA: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 108
TABLE 53 EUROPE: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 109
TABLE 54 ASIA PACIFIC: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 109
TABLE 55 LATIN AMERICA: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 56 KEY PRODUCTS IN DUAL-LIMB BREATHING CIRCUITS MARKET 111
TABLE 57 DUAL-LIMB BREATHING CIRCUITS MARKET, BY REGION 2022–2029 (USD MILLION) 111
TABLE 58 NORTH AMERICA: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY
2022–2029 (USD MILLION) 112
TABLE 59 EUROPE: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 112
TABLE 60 ASIA PACIFIC: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 113
TABLE 61 LATIN AMERICA: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 113
TABLE 62 BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 115
TABLE 63 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR ANESTHESIA 117
TABLE 64 BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY REGION 2022–2029 (USD MILLION) 118
TABLE 65 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY 2022–2029 (USD MILLION) 118
TABLE 66 EUROPE: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY 2022–2029 (USD MILLION) 119
TABLE 67 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 68 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 69 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION 121
TABLE 70 BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 71 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 72 EUROPE: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 73 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 74 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 75 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS 125
TABLE 76 BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS, BY REGION 2022–2029 (USD MILLION) 125
TABLE 77 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 78 EUROPE: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 79 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 80 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 81 BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 129
TABLE 82 BREATHING CIRCUITS MARKET FOR HOSPITALS, BY REGION 2022–2029 (USD MILLION) 131
TABLE 83 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 84 EUROPE: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY 2022–2029 (USD MILLION) 132
TABLE 85 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 86 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 87 BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS BY REGION, 2022–2029 (USD MILLION) 134
TABLE 88 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2022–2029 (USD MILLION) 134
TABLE 89 EUROPE: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 90 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 91 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 92 BREATHING CIRCUITS MARKET FOR CLINICS, BY REGION 2022–2029 (USD MILLION) 137
TABLE 93 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY 2022–2029 (USD MILLION) 137
TABLE 94 EUROPE: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 95 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY 2022–2029 (USD MILLION) 138
TABLE 96 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 97 BREATHING CIRCUITS MARKET FOR OTHER END USERS, BY REGION 2022–2029 (USD MILLION) 140
TABLE 98 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR OTHER END USERS BY COUNTRY 2022–2029 (USD MILLION) 140
TABLE 99 EUROPE: BREATHING CIRCUITS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 100 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR OTHER END USERS BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 101 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR OTHER END USERS BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 102 BREATHING CIRCUITS MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 103 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 146
TABLE 104 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 146
TABLE 105 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 146
TABLE 106 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 147
TABLE 107 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 147
TABLE 108 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 147
TABLE 109 NORTH AMERICA: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 148
TABLE 110 US: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 150
TABLE 111 US: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 150
TABLE 112 US: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 150
TABLE 113 US: BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 151
TABLE 114 US: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 151
TABLE 115 CANADA: NUMBER OF SURGICAL PROCEDURES PERFORMED, 2022 152
TABLE 116 CANADA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 152
TABLE 117 CANADA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 153
TABLE 118 CANADA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 153
TABLE 119 CANADA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 153
TABLE 120 CANADA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 154
TABLE 121 EUROPE: BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 155
TABLE 122 EUROPE: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 155
TABLE 123 EUROPE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 156
TABLE 124 EUROPE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 156
TABLE 125 EUROPE: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 156
TABLE 126 EUROPE: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 157
TABLE 127 EUROPE: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 157
TABLE 128 GERMANY: NUMBER OF SURGICAL PROCEDURES PERFORMED 2011 VS. 2021 (PER 100,000 INHABITANTS) 158
TABLE 129 GERMANY: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 159
TABLE 130 GERMANY: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 159
TABLE 131 GERMANY: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 159
TABLE 132 GERMANY: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 160
TABLE 133 GERMANY: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 160
TABLE 134 FRANCE: NUMBER OF SURGICAL PROCEDURES PERFORMED 2011 VS. 2021 (PER 100,000 INHABITANTS) 161
TABLE 135 FRANCE: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 161
TABLE 136 FRANCE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 162
TABLE 137 FRANCE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 162
TABLE 138 FRANCE: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 162
TABLE 139 FRANCE: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 163
TABLE 140 UK: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 164
TABLE 141 UK: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 164
TABLE 142 UK: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 164
TABLE 143 UK: BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 165
TABLE 144 UK: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 165
TABLE 145 ITALY: NUMBER OF SURGICAL PROCEDURES PERFORMED 2011 VS. 2021 (PER 100,000 INHABITANTS) 166
TABLE 146 ITALY: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 166
TABLE 147 ITALY: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 167
TABLE 148 ITALY: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 167
TABLE 149 ITALY: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 167
TABLE 150 ITALY: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 168
TABLE 151 SPAIN: NUMBER OF SURGICAL PROCEDURES PERFORMED 2011 VS. 2021 (PER 100,000 INHABITANTS) 168
TABLE 152 SPAIN: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 169
TABLE 153 SPAIN: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 169
TABLE 154 SPAIN: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 169
TABLE 155 SPAIN: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 170
TABLE 156 SPAIN: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 170
TABLE 157 REST OF EUROPE: SELECTED HIGH-GROWTH PROCEDURES PERFORMED IN HOSPITALS, 2011 VS. 2021 (PER 100,000 INHABITANTS) 171
TABLE 158 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 171
TABLE 159 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 171
TABLE 160 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 172
TABLE 161 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 172
TABLE 162 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 172
TABLE 163 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 175
TABLE 164 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 175
TABLE 165 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 175
TABLE 166 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 176
TABLE 167 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 176
TABLE 168 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 176
TABLE 169 ASIA PACIFIC: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 177
TABLE 170 JAPAN: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 178
TABLE 171 JAPAN: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 179
TABLE 172 JAPAN: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 179
TABLE 173 JAPAN: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 179
TABLE 174 JAPAN: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 180
TABLE 175 CHINA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 181
TABLE 176 CHINA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 181
TABLE 177 CHINA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 182
TABLE 178 CHINA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 182
TABLE 179 CHINA: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 182
TABLE 180 INDIA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 184
TABLE 181 INDIA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 184
TABLE 182 INDIA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 184
TABLE 183 INDIA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 185
TABLE 184 INDIA: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 185
TABLE 185 AUSTRALIA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 186
TABLE 186 AUSTRALIA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 186
TABLE 187 AUSTRALIA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 187
TABLE 188 AUSTRALIA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 187
TABLE 189 AUSTRALIA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 187
TABLE 190 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 188
TABLE 191 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 189
TABLE 192 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 189
TABLE 193 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 189
TABLE 194 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 190
TABLE 195 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 191
TABLE 196 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 191
TABLE 197 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 191
TABLE 198 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 192
TABLE 199 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 192
TABLE 200 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 193
TABLE 201 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 193
TABLE 202 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 194
TABLE 203 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 194
TABLE 204 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 194
TABLE 205 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 195
TABLE 206 LATIN AMERICA: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 195
TABLE 207 BRAZIL: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 196
TABLE 208 BRAZIL: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 197
TABLE 209 BRAZIL: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 197
TABLE 210 BRAZIL: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 197
TABLE 211 BRAZIL: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 198
TABLE 212 MEXICO: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 199
TABLE 213 MEXICO: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 199
TABLE 214 MEXICO: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 199
TABLE 215 MEXICO: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 200
TABLE 216 MEXICO: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 200
TABLE 217 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 201
TABLE 218 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 201
TABLE 219 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 201
TABLE 220 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 202
TABLE 221 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 202
TABLE 222 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 203
TABLE 223 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 204
TABLE 224 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 204
TABLE 225 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 204
TABLE 226 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 205
TABLE 227 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY USAGE 2022–2029 (USD MILLION) 206
TABLE 228 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY PATIENT TYPE 2022–2029 (USD MILLION) 206
TABLE 229 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 2022–2029 (USD MILLION) 207
TABLE 230 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 207
TABLE 231 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY END USER 2022–2029 (USD MILLION) 207
TABLE 232 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN BREATHING CIRCUITS MARKET 209
TABLE 233 BREATHING CIRCUITS MARKET: DEGREE OF COMPETITION 212
TABLE 234 BREATHING CIRCUITS MARKET: USAGE FOOTPRINT 216
TABLE 235 BREATHING CIRCUITS MARKET: APPLICATION FOOTPRINT 217
TABLE 236 BREATHING CIRCUITS MARKET: REGION FOOTPRINT 218
TABLE 237 BREATHING CIRCUITS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 220
TABLE 238 BREATHING CIRCUITS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 220
TABLE 239 BREATHING CIRCUITS MARKET: PRODUCT LAUNCHES, JANUARY 2021– JULY 2024 223
TABLE 240 BREATHING CIRCUITS MARKET: DEALS, JANUARY 2021– JULY 2024 224
TABLE 241 DR?GERWERK AG & CO. KGAA: COMPANY OVERVIEW 225
TABLE 242 DR?GERWERK AG & CO. KGAA: PRODUCTS OFFERED 227
TABLE 243 DR?GERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024 228
TABLE 244 DR?GERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JULY 2024 228
TABLE 245 MEDTRONIC: COMPANY OVERVIEW 230
TABLE 246 MEDTRONIC: PRODUCTS OFFERED 231
TABLE 247 MEDTRONIC: DEALS, JANUARY 2021–JULY 2024 232
TABLE 248 CARDINAL HEALTH.: COMPANY OVERVIEW 234
TABLE 249 CARDINAL HEALTH: PRODUCTS OFFERED 235
TABLE 250 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–JULY 2024 236
TABLE 251 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 238
TABLE 252 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED 239
TABLE 253 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS JANUARY 2021–JULY 2024 240
TABLE 254 RESMED: COMPANY OVERVIEW 241
TABLE 255 RESMED: PRODUCTS OFFERED 242
TABLE 256 RESMED: EXPANSIONS, JANUARY 2021–JULY 2024 243
TABLE 257 AMBU A/S: COMPANY OVERVIEW 244
TABLE 258 AMBU A/S: PRODUCTS OFFERED 246
TABLE 259 AMBU A/S: EXPANSIONS, JANUARY 2021–JULY 2024 246
TABLE 260 GE HEALTHCARE: COMPANY OVERVIEW 247
TABLE 261 GE HEALTHCARE: PRODUCTS OFFERED 248
TABLE 262 GE HEALTHCARE: DEALS, JANUARY 2021–JULY 2024 249
TABLE 263 GE HEALTHCARE: EXPANSIONS, JANUARY 2021–JULY 2024 249
TABLE 264 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 250
TABLE 265 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 251
TABLE 266 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JULY 2024 252
TABLE 267 ICU MEDICAL, INC.: COMPANY OVERVIEW 253
TABLE 268 ICU MEDICAL, INC.: PRODUCTS OFFERED 255
TABLE 269 ICU MEDICAL, INC.: DEALS, JANUARY 2021–JULY 2024 255
TABLE 270 HAMILTON MEDICAL: COMPANY OVERVIEW 256
TABLE 271 HAMILTON MEDICAL: PRODUCTS OFFERED 256
TABLE 272 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 257
TABLE 273 MEDLINE INDUSTRIES, LP: PRODUCTS OFFERED 257
TABLE 274 MEDLINE INDUSTRIES, LP: DEALS, JANUARY 2021–JULY 2024 258
TABLE 275 MEDLINE INDUSTRIES, LP: EXPANSIONS, JANUARY 2021–JULY 2024 259
TABLE 276 FORCA HEALTHCARE: COMPANY OVERVIEW 260
TABLE 277 BRAUN & CO. LIMITED: COMPANY OVERVIEW 261
TABLE 278 INSPIRATION HEALTHCARE GROUP PLC: COMPANY OVERVIEW 262
TABLE 279 BESMED HEALTH BUSINESS CORP.: COMPANY OVERVIEW 263
TABLE 280 EAKIN HEALTHCARE: COMPANY OVERVIEW 264
TABLE 281 BOMIMED: COMPANY OVERVIEW 265
TABLE 282 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 266
TABLE 283 BIO-MED DEVICES: COMPANY OVERVIEW 267
TABLE 284 AIRLIFE: COMPANY OVERVIEW 268
TABLE 285 MERCURY MEDICAL: COMPANY OVERVIEW 269
TABLE 286 INTERSURGICAL LTD.: COMPANY OVERVIEW 270
TABLE 287 FAIRMONT MEDICAL PRODUCTS PTY LTD.: COMPANY OVERVIEW 271
TABLE 288 BREAS MEDICAL AB: COMPANY OVERVIEW 272
TABLE 289 GPC MEDICAL LTD.: COMPANY OVERVIEW 273